Live feed17:06:55·140dINSIDERFilingvia QuantisnowDirector Abecassis Michael M was granted 37,500 shares and covered exercise/tax liability with 16,875 shares, increasing direct ownership by 1,237% to 22,292 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.PMCB· PharmaCyte Biotech Inc.Health CareOriginal source